Your browser doesn't support javascript.
loading
Gene-gene functional relationships in Alzheimer's disease: CELF1 regulates KLC1 alternative splicing.
Kikuchi, Masataka; Viet, Justine; Nagata, Kenichi; Sato, Masahiro; David, Geraldine; Audic, Yann; Silverman, Michael A; Yamamoto, Mitsuko; Akatsu, Hiroyasu; Hashizume, Yoshio; Takeda, Shuko; Akamine, Shoshin; Miyamoto, Tesshin; Uozumi, Ryota; Gotoh, Shiho; Mori, Kohji; Ikeda, Manabu; Paillard, Luc; Morihara, Takashi.
Afiliação
  • Kikuchi M; Department of Genome Informatics, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Viet J; Université de Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes), UMR 6290, F-35000, Rennes, France.
  • Nagata K; Department of Functional Anatomy and Neuroscience, Graduate School of Medicine, Nagoya University, Nagoya, Japan.
  • Sato M; Department of Psychiatry, Graduate School of Medicine, Osaka University, Suita, Japan.
  • David G; Université de Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes), UMR 6290, F-35000, Rennes, France.
  • Audic Y; Université de Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes), UMR 6290, F-35000, Rennes, France.
  • Silverman MA; Department of Biological Sciences, Centre for Cell Biology, Development, and Disease, Simon Fraser University, Burnaby, Canada.
  • Yamamoto M; Department of Psychiatry, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Akatsu H; Department of Community-based Medical Education, Graduate School of Medicine, Nagoya City University, Nagoya, Japan; Choju Medical/Neuropathological Institute, Fukushimura Hospital, Toyohashi, Japan.
  • Hashizume Y; Fukushimura Hospital, Toyohashi, Japan.
  • Takeda S; Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, Suita, Japan; Osaka Psychiatric Medical Center, Osaka Psychiatric Research Center, Hirakata, Japan.
  • Akamine S; Department of Psychiatry, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Miyamoto T; Department of Psychiatry, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Uozumi R; Department of Psychiatry, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Gotoh S; Department of Psychiatry, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Mori K; Department of Psychiatry, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Ikeda M; Department of Psychiatry, Graduate School of Medicine, Osaka University, Suita, Japan.
  • Paillard L; Université de Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes), UMR 6290, F-35000, Rennes, France. Electronic address: luc.paillard@univ-rennes.fr.
  • Morihara T; Department of Psychiatry, Graduate School of Medicine, Osaka University, Suita, Japan; Toyonaka Municipal Hospital, Toyonaka, Japan. Electronic address: morihara@psy.med.osaka-u.ac.jp.
Biochem Biophys Res Commun ; 721: 150025, 2024 Aug 20.
Article em En | MEDLINE | ID: mdl-38768546
ABSTRACT
The causes of Alzheimer's disease (AD) are poorly understood, although many genes are known to be involved in this pathology. To gain insights into the underlying molecular mechanisms, it is essential to identify the relationships between individual AD genes. Previous work has shown that the splice variant E of KLC1 (KLC1_vE) promotes AD, and that the CELF1 gene, which encodes an RNA-binding protein involved in splicing regulation, is at a risk locus for AD. Here, we identified a functional link between CELF1 and KLC1 in AD pathogenesis. Transcriptomic data from human samples from different ethnic groups revealed that CELF1 mRNA levels are low in AD brains, and the splicing pattern of KLC1 is strongly correlated with CELF1 expression levels. Specifically, KLC1_vE is negatively correlated with CELF1. Depletion and overexpression experiments in cultured cells demonstrated that the CELF1 protein down-regulates KLC1_vE. In a cross-linking and immunoprecipitation sequencing (CLIP-seq) database, CELF1 directly binds to KLC1 RNA, following which it likely modulates terminal exon usage, hence KLC1_vE formation. These findings reveal a new pathogenic pathway where a risk allele of CELF1 is associated with reduced CELF1 expression, which up-regulates KLC1_vE to promote AD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Processamento Alternativo / Doença de Alzheimer / Proteínas CELF1 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Processamento Alternativo / Doença de Alzheimer / Proteínas CELF1 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article